Ascendis Pharma is a biopharmaceutical company based in Copenhagen, Denmark, that develops long-acting medicines by attaching a drug to a carrier molecule so it releases slowly in the body. Its products treat hormone-related conditions, including growth hormone deficiency in children and low parathyroid hormone in adults. The company serves patients and healthcare providers through specialty medicine markets, and it also runs a commercial operation alongside its research and development work.
Ascendis Pharma A/S is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1SN34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #738 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
50/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-5.0%
From 52-week high-18.7%
MomentumWeak
45/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-17.1%
6-month return0.6%
12-month, skipping last month21.8%
Stability (higher is calmer)Strong
77/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)29.9%
Worst drawdown, 1 year (smaller is calmer)-19.5%
LiquidityWeak
20/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M BRL
Zero-volume days71.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 70.00 – 94.05Daily closes, split-adjusted
Signals
50-day average83.90
200-day average80.51
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.56
Technical summary
Daily
Strongly bearish
2 bullish · 3 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 8 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
75.97
Bullish
EMA 10
76.54
Bearish
SMA 20
76.87
Bearish
EMA 20
78.36
Bearish
SMA 50
83.90
Bearish
EMA 50
81.96
Bearish
SMA 100
84.66
Bearish
EMA 100
82.62
Bearish
SMA 200
80.51
Bearish
EMA 200
79.94
Bearish
Oscillators (daily)
RSI (14)
28.62
Bullish
MACD (12, 26)
-2.59
Bearish
Momentum (12)
-1.04
Bearish
Stochastic %K (14)
47.71
Neutral
Williams %R (14)
-52.29
Neutral
CCI (20)
-35.93
Neutral
Pivot points (classic, last session)
S3
76.48
S2
76.48
S1
76.48
Pivot
76.48
R1
76.48
R2
76.48
R3
76.48
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
